Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study on promotion of appetite after olanzapine in healthy volunteers
DRKS00006854Phase 4Completed
- Sponsor
- Max Planck Institute of Psychiatry
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of olanzapine, sponsored by Max Planck Institute of Psychiatry. Primary endpoint: Appetite promotion after olanzapine. Started Nov 2014; status: completed.
02
Drugs
olanzapine
Beyond the preview
Go deeper on DRKS00006854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00006854.